Squarepoint Ops LLC Gamida Cell Ltd. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.25 - $1.02 $130,568 - $532,720	522,275 Added 2551.92%	542,741 $222,000
Q2 2023 Aug 14, 2023	BUY	$0.73 - $2.37 $14,940 - $48,504	20,466 New	20,466 $39,000
Q1 2021 May 17, 2021	SELL	$7.8 - $12.43 $282,461 - $450,127	-36,213 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.07 - $11.0 $43,390 - $117,271	-10,661 Reduced 22.74%	36,213 $304,000
Q3 2020 Nov 16, 2020	BUY	$3.93 - $4.59 $184,214 - $215,151	46,874 New	46,874 $195,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.